¨ Quality Excellence & International Regulatory Compliance:

Continuous enhancement of product quality in alignment with leading pharmacopeias and Good Manufacturing Practice (GMP) regulations, to ensure sustainable safeguarding of public health.

¨ Product Portfolio Expansion & Supply Chain Resilience:

Targeted diversification of the pharmaceutical portfolio, scaling up production capacity for vital medicines, and ensuring uninterrupted supply to effectively meet national healthcare needs.

¨ Infrastructure Modernization & Operational Process Effectiveness:

Adoption of advanced manufacturing technologies, optimal resource utilization, and productivity enhancement across production lines to drive continuous efficiency throughout the pharmaceutical value chain.

¨ Market Share Growth & Regional Presence:

Expanding the company’s domestic market share, deepening commercial partnerships across distribution networks, and establishing a targeted presence in international pharmaceutical markets.

¨ Strategic Human Capital Development & Commitment to HSE Principles:

Enhancing the competencies and professional capabilities of human resources, maintaining the highest standards of occupational health and safety, and fostering responsible environmental stewardship across all stages of pharmaceutical manufacturing.